Skip to main content
Log in

Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis

International Journal of Hematology Aims and scope Submit manuscript

Abstract

The current therapeutic strategy for disseminated intravascular coagulation (DIC) is limited to control of the underlying disease, and methods for the effective management of DIC have not been established. We report the successful use of tranexamic acid (TA) combined with unfractionated heparin in a patient with life-threatening bleeding from the sigmoid colon caused by DIC. A 35-year-old man who had undergone allogeneic bone marrow transplantation for chronic myelogenous leukemia was referred for relapse of his leukemia. The patient was first treated with imatinib at 600 mg/day. Although the disappearance of leukemic cells and a decrease in the BCR/ABL fusion gene were observed, he developed massive bleeding from the sigmoid colon after defecation. A laboratory diagnosis of DIC with prominent fibrinolysis was based on elevated levels of both plasmin-α2-plasmin inhibitor complex and thrombin-antithrombin III complex. Despite vigorous supportive therapy, including multiple transfusions and aggressive fluid resuscitation, the patient developed hypovolemic shock due to the uncontrollable bleeding. TA combined with unfractionated heparin was instituted to inhibit excessive fibrinolysis. A prompt response was observed soon after the commencement of therapy. No organ dysfunction was observed throughout TA and heparin use. To our knowledge, this report is the first to describe successful treatment with TA combined with heparin for life-threatening intestinal bleeding due to acute DIC associated with hematologic malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Levi M, Cate HT. Disseminated intravascular coagulation.N Engl J Med. 1999;341:586–592.

    Article  PubMed  CAS  Google Scholar 

  2. Tallman MS, Kwaan HC. Reassessing the hematostatic disorder associated with acute promyelocytic leukemia.Blood. 1992;79:543–553.

    PubMed  CAS  Google Scholar 

  3. Levi M. Current understanding of disseminated intravascular coagulation.Br J Haematol. 2004;124:567–576.

    Article  PubMed  Google Scholar 

  4. Barbui T, Falanga A. Disseminated intravascular coagulation in acute leukemia.Semin Thromb Hemost. 2001;27:593–604.

    Article  PubMed  CAS  Google Scholar 

  5. Hanna BD, Bernstein M, Tranexamic acid in the treatment of Kasabach-Merritt syndrome in infants.Am J Pediatr Hematol Oncol. 1989;11:191–195.

    PubMed  CAS  Google Scholar 

  6. Takada A, Takada Y, Mori T, Sakaguchi S. Prevention of severe bleeding by tranexamic acid in a patient with disseminated intravascular coagulation.Thromb Res. 1990;58:101–108.

    Article  PubMed  CAS  Google Scholar 

  7. Wada H, Kumeda Y, Ogasawara Z, et al. Plasminogen activators and their inhibitors in leukemic cell homogenates.Am J Hematol. 1993;42:166–170.

    Article  PubMed  CAS  Google Scholar 

  8. Robbie L, Berry S, Moir E, et al. Myeloid leukemic cells can lyse fibrin directly.Br J Haematol. 2000;111:524–529.

    Article  PubMed  CAS  Google Scholar 

  9. Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Leu EA, Hajjar KA. Annexin II and bleeding in acute promyelocytic leukemia.N Engl J Med. 1999;340:994–1004.

    Article  PubMed  CAS  Google Scholar 

  10. Asakura H, Jokaji H, Saito M, et al. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.Blood Coagul Fibrinolysis. 1994;5:829–832.

    Article  PubMed  CAS  Google Scholar 

  11. Asakura H, Sano Y, Yamazaki M, Morishita E, Miyamoto K, Nakao S. Role of fibrinolysis in tissue-factor-induced disseminated intravascular coagulation in rats: an effect of tranexamic acid.Haematologica. 2004;89:757–758.

    PubMed  Google Scholar 

  12. Avvisati G, ten Cate JW, Büller HR, Mandelli F. Tranexamic acid for control of haemorrhage in acute promyelocytic leukemia.Lancet. 1989;2:122–124.

    Article  PubMed  CAS  Google Scholar 

  13. Rodeghiero F, Avvisati G, Castaman G, Barbui T, Mandelli F. Early death and anti-hemorrhagic treatments in acute promyelocytic leukemia: A GIMEMA retrospective study in 268 consecutive patients.Blood. 1990;75:2112–2117.

    PubMed  CAS  Google Scholar 

  14. Sanz MA, Martín G, González M, et al. Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monotherapy: a multicenter study by the PETHEMA group.Blood. 2004;103:1237–1243.

    Article  PubMed  CAS  Google Scholar 

  15. Hashimoto S, Koike T, Tatewaki W, et al. Fatal thromboembolism in acute promyelocytic leukemia during all-trans-retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage.Leukemia. 1994;8:1113–1115.

    PubMed  CAS  Google Scholar 

  16. Ontachi Y, Asakura H, Arahata M, et al. Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm.Circ J. 2005;69:1150–1153.

    Article  PubMed  Google Scholar 

  17. Ontachi Y, Asakura H, Omote M, Yoshida T, Matsui O, Nakao S. Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid.Haematologica. 2005;90(Suppl):ECR29.

    PubMed  Google Scholar 

  18. Kario K, Matsuo T, Kodama K, Matsuo M, Yamamoto K, Kobayashi H. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation: assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.Haemostasis. 1992;22:179–186.

    PubMed  CAS  Google Scholar 

  19. Okajima K, Kohno I, Soe G, Okabe H, Takatsuki K, Binder BR. Direct evidence for systemic fibrinogenolysis in patients with acquired alpha 2-plasmin inhibitor deficiency.Am J Hematol. 1994;45:16–24.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kosei Matsue.

About this article

Cite this article

Koseki, M., Asada, N., Uryu, H. et al. Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis. Int J Hematol 86, 403–406 (2007). https://doi.org/10.1007/BF02983996

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02983996

Key words

Navigation